#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14518	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2365	748.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1549	1549	C	903	C,G	900,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24748	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4045	762.3	0	.	n	.	0	T695C	SNP	695	695	T	1292	1292	C	894	C,G	893,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24748	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4045	762.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1934	1934	A	978	A,C,G	976,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24748	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4045	762.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2568	2568	C	907	C,G,A	902,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24748	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4045	762.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2642	2642	A	849	A,T,G	845,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24748	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4045	762.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3194	3194	C	857	C,G,T	853,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24748	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4045	762.3	0	HET	.	.	.	C265T,A	.	265	265	C	862	862	C	931	C,T,A	721,207,3	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2226	folP	855	855	100.0	folP.l15.c4.ctg.1	2027	137.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1287	1289	AGC	238;243;245	A,G;G;C,T,G	237,1;243;242,2,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5414	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4016	167.9	1	SNP	p	S91F	1	.	.	271	273	TTC	824	826	TTC	199;202;202	T;T;C	199;202;202	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5414	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4016	167.9	1	SNP	p	D95G	1	.	.	283	285	GGC	836	838	GGC	199;196;195	G,A;G;C,A	198,1;196;194,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5414	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4016	167.9	1	SNP	p	G95N	0	.	.	283	285	GGC	836	838	GGC	199;196;195	G,A;G;C,A	198,1;196;194,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1960	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1740	140.2	1	SNP	p	G45D	0	.	.	133	135	GGC	735	737	GGC	254;256;257	G;G,C;C,T	254;255,1;256,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1142	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1362	104.0	0	.	n	.	0	A197.	DEL	197	197	A	761	761	A	215	A	215	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3387	183.0	1	SNP	p	D86N	0	.	.	256	258	GAC	807	809	GAC	240;238;235	G;A;C,G,A	240;238;233,1,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3387	183.0	1	SNP	p	R87W	0	.	.	259	261	CGT	810	812	CGT	233;235;239	C,G;G;T,C	232,1;235;238,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3387	183.0	1	SNP	p	S87R	1	.	.	259	261	CGT	810	812	CGT	233;235;239	C,G;G;T,C	232,1;235;238,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3387	183.0	1	SNP	p	R87I	0	.	.	259	261	CGT	810	812	CGT	233;235;239	C,G;G;T,C	232,1;235;238,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4978	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3387	183.0	1	SNP	p	S88P	0	.	.	262	264	TCC	813	815	TCC	243;243;243	T;C;C,T	243;243;242,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4406	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3109	176.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1801	1803	GGC	249;249;251	G;G,A;C	249;248,1;251	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1490	1492	GCA	231;229;234	G,A,T;C,G,A;A	229,1,1;227,1,1;234	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1493	1495	ATC	236;235;231	A;T;C	236;235;231	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1505	1507	GTG	246;244;245	G,A;T;G	245,1;244;245	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1505	1507	GTG	246;244;245	G,A;T;G	245,1;244;245	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2009	2011	ACC	251;250;252	A,C;C;C	250,1;250;252	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2063	2065	GCG	239;240;238	G,A;C;G,A,C	238,1;240;236,1,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2063	2065	GCG	239;240;238	G,A;C;G,A,C	238,1;240;236,1,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2186	2188	AGC	202;203;208	A,C;G,A,C;C,A	200,2;201,1,1;207,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2195	2197	GGC	211;210;208	G,T,C;G,T,C;C,T	209,1,1;208,1,1;207,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4042	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2901	173.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2213	2215	CCG	219;221;222	C,G,A;C,G,T,A;G,C,A	217,1,1;217,2,1,1;220,1,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5478	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3698	184.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1941	1943	CCG	219;220;217	C,G,A;C,T,G;G,T	217,1,1;217,2,1;216,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2544	porA	1146	1146	99.91	porA.l6.c30.ctg.1	2281	139.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	828	828	C	217	C	216	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	34;35;39	T;T;A	34;35;39	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	74;74;74	C;A;T	74;74;74	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	74;74;74	A;G;T	74;74;74	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	74;74;74	T;A;C	74;74;74	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	304	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	265	35.8	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	2;2;2	G;T;T	2;2;2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2858	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1881	187.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	589	591	GAA	250;247;244	G;A,C;A,G	250;246,1;243,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2858	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1881	187.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	877	879	GAT	234;230;232	G;A,C;T	234;229,1;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2858	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1881	187.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1000	1002	TCA	247;248;252	T,A;C;A	246,1;248;252	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2858	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1881	187.9	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1129	1131	ATC	262;262;261	A,G;T;C	261,1;262;261	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2858	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1881	187.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1459	1461	GCA	216;217;215	G,A,T;C;A	214,1,1;217;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2858	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1881	187.9	1	SNP	p	G120K	1	.	.	358	360	AAG	835	837	AAG	244;246;246	A,C;A;G,C	243,1;246;245,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2858	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1881	187.9	1	SNP	p	D121N	0	.	.	361	363	GAC	838	840	GAC	244;245;248	G,A;A;C,T,G	243,1;245;246,1,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2858	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1881	187.9	1	SNP	p	A121D	1	.	.	361	363	GAC	838	840	GAC	244;245;248	G,A;A;C,T,G	243,1;245;246,1,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9266	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5290	218.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1364	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1623	105.0	1	SNP	p	V57M	1	.	.	169	171	ATG	844	846	ATG	250;250;249	A;T;G	250;250;249	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
